Celldex Therapeutics, Inc.
Head Quarters
53 Frontage Road Perryville III Building USWebsite
http://www.celldex.comIndustry
BiotechnologyEmployees
210Exchange
NASDAQCelldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 6 |
| Gross Margin (%) | 0.00% |
| Net Margin (%) | -4.86% |
| Returns | Stock |
| Sales | $7.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$35.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 4,331.61 |
| EPS | -$1.00 |